| Literature DB >> 32342043 |
Abhishek S Prayag1, Mirjam Münch2,3,4, Daniel Aeschbach5,6, Sarah L Chellappa6,7, Claude Gronfier1.
Abstract
Light, through its non-imaging forming effects, plays a dominant role on a myriad of physiological functions, including the human sleep-wake cycle. The non-image forming effects of light heavily rely on specific properties such as intensity, duration, timing, pattern, and wavelengths. Here, we address how specific properties of light influence sleep and wakefulness in humans through acute effects, e.g., on alertness, and/or effects on the circadian timing system. Of critical relevance, we discuss how different characteristics of light exposure across the 24-h day can lead to changes in sleep-wake timing, sleep propensity, sleep architecture, and sleep and wake electroencephalogram (EEG) power spectra. Ultimately, knowledge on how light affects sleep and wakefulness can improve light settings at home and at the workplace to improve health and well-being and optimize treatments of chronobiological disorders.Entities:
Keywords: EEG activity; alertness and ipRGCs; circadian; light; melanopsin; melatonin; non-image forming; sleep; wake
Year: 2019 PMID: 32342043 PMCID: PMC7185269 DOI: 10.3390/clockssleep1010017
Source DB: PubMed Journal: Clocks Sleep ISSN: 2624-5175
Overview of references.
| Section | Key References |
|---|---|
| Spectral sensitivity of | |
| Duration response curves for | |
| Phase response curves (Khalsa et al. [ | |
| Illuminance response curves for | |
| (i) Intermittent bright light and circadian phase-shifting (Rimmer et al. [ | |
| (i) melatonin suppression (Visser et al. [ | |
| Influence of light history on non-visual responses (Hébert et al. [ | |
| Influence of bright light and short-wavelength light on the waking EEG (Badia et al. [ | |
| (i) Impact of brighter light during daytime increases SWS accumulation during the following night (Wams et al. [ |
Figure 1Action spectrum of acute melatonin suppression by light in humans. Wavelength-dependent melatonin suppression (expressed relative to control-adjusted (CA) melatonin suppression) after 60 min monochromatic light exposures, at night, at 3.6 × 1013 photons/cm2/s. The fit (solid blue curve) is a four parameter Gaussian model (R2 = 0.94). Maximum suppression was found at 484 nm (λmax). Figure and legend adapted from [29].
Figure 2Duration–response curves of melatonin phase shifts (left) and suppression (right) in humans. Open symbols represent responses to light exposure durations of 0.2 h, 1 h, 2.5 h, and 4.0 h respectively. Filled symbols represent a dim background control and a 6.5 polychromatic white light exposure [42]. The fits (solid blue curve) are a 4-parameter logistic model. Predicted half-maximum values are shown by the dotted lines. Figures and legend adapted from [32].
Figure 3The human phase response curve to 6.7 h of 10,000 lux polychromatic white light. Circadian phase advances are shown as positive, and circadian phase delays as negative values on the y-axis. They are plotted against the timing of the center of light exposure relative to the plasma melatonin midpoint on the pre-stimulus constant routine (defined to be at circadian phase hour 22), with the core body temperature minimum assumed to occur 2 h later, at circadian phase hour 0 (at 05:30 on average). The solid blue curve is the dual harmonic function fitted through all the individual data points. The horizontal dotted line indicates the anticipated 0.54 h average delay drift of the pacemaker between the pre- and post-stimulus phase assessments. The open squares are data obtained from plasma melatonin samples, the filled square represents salivary melatonin data for one subject. Figure and legend adapted from [6].
Figure 4Illuminance response curves to a 6.5 h polychromatic white light exposure for melatonin phase shift (left) and melatonin suppression (right) in humans. Individual subjects are indicated by the open squares, the solid blue line shows the sigmoidal curve fitting. Note that the curves and x-axes have been extended to include response levels at very low light intensities. The reader is referred to Figure 5 to compare the melanopic illuminance-response model (1.5 h light exposure) with the illuminance-response model here (6.5 h light exposure). Figures and legend adapted from [38].
Figure 5Melatonin suppression threshold and saturation as a function of melanopic lux, in humans. Left: In colored points, the control-adjusted percentage melatonin suppression for the nine wavelengths used in Brainard et al. (2001, 2008) [27,74]. Light intensities used in those two studies are expressed in melanopic illuminance (melanopic lux). Right: Melanopic illuminance-response model of the normalized melatonin suppression response in humans. The horizontal dotted lines correspond to 10% (initiation), 50% (half-maximum response), and 90% (saturation) of the suppression response following 1.5 h exposure to monochromatic lights at night. The initiation threshold for melatonin suppression corresponds to ~1.5 melanopic lux, the half-maximum at ~21 melanopic lux, and saturation begins at 305 melanopic lux. Solid lines represent the sigmoidal fitting. Figure and legend adapted from [40].
Figure 6Variation in the human electroencephalogram (EEG) spectra during daytime and nighttime monochromatic light exposure. Log-transformed averaged EEG power density during 6.5 h monochromatic light exposure (460 nm and 555 nm, equal photon density of 2.8 × 1013 photons/cm2/s) was expressed relative to EEG power density during the same clock time 48 h earlier (dim light < 3 lux) under constant routine (100%, dotted line). Average EEG power density in each 0.5 Hz frequency bin was compared between 460 nm and 555 nm exposure during daytime (A) and nighttime (B). Comparisons between daytime and nighttime for the 460 nm (C) and 555 nm (D) exposures are also shown. Differences between blue and green monochromatic lights (panels A,B), and between daytime and nighttime (panels C,D) are denoted by * (p < 0.05). Figure and legend adapted from [11,55].